Literature DB >> 23610720

Five-year survival of alpha-fetoprotein-producing gastric cancer with synchronous liver metastasis: a case report.

Kenji Koneri1, Yasuo Hirono, Daisuke Fujimoto, Katsuji Sawai, Mitsuhiro Morikawa, Makoto Murakami, Takanori Goi, Atsushi Iida, Kanji Katayama, Akio Yamaguchi.   

Abstract

Alpha-fetoprotein-Producing gastric cancer is associated with poor prognosis because of frequent liver and lymph node metastasis. We present a case with synchronous liver metastasis who survived for 5 years. A 69-year-old man with upper abdominal pain was referred to our hospital. Gastrointestinal endoscopy revealed a Borrmann II-like tumor in the lower part of the stomach. Computed tomography revealed a tumor in the left lobe of the liver. Serum alpha-fetoprotein levels were markedly increased. We performed distal gastrectomy after administering oral tegafur/gimeracil/oteracil potassium and administered hepatic intra-arterial cisplatin injection. Liver metastasis showed partial response on computed tomography. Despite left hepatic lobectomy, further metastases to the liver and mediastinal lymph nodes became difficult to control. After sorafenib tosylate administration, stabilization of the disease was observed for 4 months. We conclude that hepatic intra-arterial chemotherapy and oral administration of sorafenib tosylate may potentially improve the prognosis in such cases.

Entities:  

Keywords:  Alpha-fetoproteins; Drug therapy; General surgery; Sorafenib; Stomach neoplasms

Year:  2013        PMID: 23610720      PMCID: PMC3627808          DOI: 10.5230/jgc.2013.13.1.58

Source DB:  PubMed          Journal:  J Gastric Cancer        ISSN: 1598-1320            Impact factor:   3.720


  14 in total

Review 1.  [A case of AFP-producing gastric cancer with multiple liver metastases responding to CPT-11 and cisplatin combination chemotherapy].

Authors:  Takeshi Asami; Atsushi Kokawa; Kazuya Sugimori; Naohiko Tomita; Kazuhito Shirato; Manabu Morimoto; Toshifumi Saito; Katsuaki Tanaka; Toshio Imada
Journal:  Gan To Kagaku Ryoho       Date:  2002-11

2.  Biological aggressiveness of alpha-fetoprotein (AFP)-positive gastric cancer.

Authors:  Sumiya Ishigami; Shoji Natsugoe; Hiroshi Nakashima; Koki Tokuda; Akihiro Nakajo; Hiroshi Okumura; Masataka Matsumoto; Saburo Nakashima; Shuichi Hokita; Takashi Aikou
Journal:  Hepatogastroenterology       Date:  2006 May-Jun

3.  Clinicopathologic features of gastric cancers producing alpha-fetoprotein.

Authors:  Koji Kono; Hideki Amemiya; Takayoshi Sekikawa; Hidehiko Iizuka; Akihiro Takahashi; Hideki Fujii; Yoshiro Matsumoto
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

4.  Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer.

Authors:  Chul Kim; Jae-Lyun Lee; Yoon Hee Choi; Byung Woog Kang; Min-Hee Ryu; Heung Moon Chang; Tae Won Kim; Yoon-Koo Kang
Journal:  Invest New Drugs       Date:  2010-09-14       Impact factor: 3.850

5.  c-Met: A potential therapeutic target for hepatocellular carcinoma.

Authors:  J J Gao; Y Inagaki; X Xue; X J Qu; W Tang
Journal:  Drug Discov Ther       Date:  2011-02

6.  [Hepatic arterial injection therapy (HAI) for metastatic liver tumor from gastric cancer].

Authors:  T Nagahama; M Maruyama; Y Toukairin; H Baba; T Yoshida; N Kure; M Ebuchi; F Yamada; T Ikeda
Journal:  Gan To Kagaku Ryoho       Date:  2000-10

7.  Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer.

Authors:  M Inoue; T Sano; A Kuchiba; H Taniguchi; T Fukagawa; H Katai
Journal:  Br J Surg       Date:  2010-07       Impact factor: 6.939

8.  AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients.

Authors:  Yosuke Adachi; Junko Tsuchihashi; Norio Shiraishi; Kazuhiro Yasuda; Tsuyoshi Etoh; Seigo Kitano
Journal:  Oncology       Date:  2003       Impact factor: 2.935

9.  FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer.

Authors:  Mitsugu Kochi; Masashi Fujii; Teruo Kaiga; Toru Takahashi; Yukie Morishita; Michiyo Kobayashi; Yuichi Kasakura; Tadatoshi Takayama
Journal:  Oncology       Date:  2004       Impact factor: 2.935

10.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

View more
  3 in total

1.  Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases.

Authors:  Y U Fang; Lin Wang; Ningrong Yang; Xinlei Gong; Y U Zhang; Shukui Qin
Journal:  Oncol Lett       Date:  2015-09-21       Impact factor: 2.967

2.  Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report.

Authors:  Yasuhiro Arakawa; Miho Tamura; Keisuke Aiba; Kazuhiko Morikawa; Daisuke Aizawa; Masahiro Ikegami; Masami Yuda; Katsunori Nishikawa
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

3.  Metachronous Liver Metastasis from Alpha-Fetoprotein-Producing Gastric Cancer Successfully Treated with Capecitabine/Oxaliplatin Combination Chemotherapy.

Authors:  Soichi Furukawa; Takashi Kobayashi; Saori Shiono; Shuta Nishinakagawa
Journal:  Case Rep Surg       Date:  2022-08-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.